Click to view |
Rank |
Structure template |
TM-score1 |
TM-score2 |
Foldseek E-value |
Length |
ID1 |
ID2 |
Download |
Description |
|
|
1
|
AFDB:A0A0B4J1S8
|
0.730
|
0.720
|
0.000
|
828
|
1.000
|
0.986
|
A0A0B4J1S8.pdb.gz
|
A0A0B4J1S8_HUMAN Phosphatidylinositol 4-kinase beta OS=Homo sapiens OX=9606 GN=PI4KB PE=1 SV=1
|
|
|
2
|
AFDB:Q49GP3
|
0.804
|
0.787
|
1.304E-98
|
835
|
0.822
|
0.804
|
Q49GP3.pdb.gz
|
PI4KB_DANRE Phosphatidylinositol 4-kinase beta OS=Danio rerio OX=7955 GN=pi4kb PE=2 SV=2
|
|
|
3
|
AFDB:Q20077
|
0.601
|
0.734
|
1.942E-44
|
666
|
0.308
|
0.377
|
Q20077.pdb.gz
|
Q20077_CAEEL PI3K/PI4K domain-containing protein OS=Caenorhabditis elegans OX=6239 GN=pifk-1 PE=1 SV=2
|
|
|
4
|
AFDB:P54677
|
0.593
|
0.416
|
8.724E-37
|
1180
|
0.293
|
0.203
|
P54677.pdb.gz
|
PI4K_DICDI Phosphatidylinositol 4-kinase OS=Dictyostelium discoideum OX=44689 GN=pikD PE=3 SV=3
|
|
|
5
|
AFDB:Q9UW24
|
0.551
|
0.472
|
1.710E-35
|
956
|
0.276
|
0.235
|
Q9UW24.pdb.gz
|
PIK1A_CANAL Phosphatidylinositol 4-kinase PIK1a OS=Candida albicans (strain SC5314 / ATCC MYA-2876) OX=237561 GN=PIKA PE=3 SV=1
|
|
|
6
|
AFDB:Q9UW20
|
0.581
|
0.487
|
7.225E-35
|
977
|
0.294
|
0.246
|
Q9UW20.pdb.gz
|
PIK1_CANAL Phosphatidylinositol 4-kinase PIK1alpha OS=Candida albicans (strain SC5314 / ATCC MYA-2876) OX=237561 GN=PIKALPHA PE=3 SV=1
|
|
|
7
|
AFDB:P39104
|
0.580
|
0.448
|
1.385E-34
|
1066
|
0.289
|
0.221
|
P39104.pdb.gz
|
PIK1_YEAST Phosphatidylinositol 4-kinase PIK1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PIK1 PE=1 SV=1
|
|
|
8
|
AFDB:Q9FMJ0
|
0.587
|
0.432
|
2.656E-34
|
1121
|
0.294
|
0.214
|
Q9FMJ0.pdb.gz
|
P4KB1_ARATH Phosphatidylinositol 4-kinase beta 1 OS=Arabidopsis thaliana OX=3702 GN=PI4KB1 PE=1 SV=1
|
|
|
9
|
AFDB:Q580E2
|
0.576
|
0.800
|
1.287E-31
|
581
|
0.196
|
0.275
|
Q580E2.pdb.gz
|
Q580E2_TRYB2 Phosphatidylinositol 4-kinase, putative OS=Trypanosoma brucei brucei (strain 927/4 GUTat10.1) OX=185431 GN=Tb04.5E12.290 PE=4 SV=1
|
|
|
10
|
AFDB:F1RCP0
|
0.507
|
0.207
|
5.055E-28
|
2059
|
0.180
|
0.071
|
F1RCP0.pdb.gz
|
|
|
|
11
|
PDB:5dxhD
|
0.443
|
0.372
|
2.252E-15
|
981
|
0.119
|
0.099
|
5dxhD.pdb.gz
|
The Rational Design of Selective Benzoxazepin Inhibitors of the alpha-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326).
|
|
|
12
|
PDB:7mezA
|
0.470
|
0.393
|
2.359E-15
|
989
|
0.140
|
0.115
|
7mezA.pdb.gz
|
|
|
|
13
|
PDB:4yknA
|
0.455
|
0.315
|
2.589E-15
|
1205
|
0.120
|
0.081
|
4yknA.pdb.gz
|
Discovery of a Potent Class of PI3K alpha Inhibitors with Unique Binding Mode via Encoded Library Technology (ELT).
|
|
|
14
|
PDB:6gy0A
|
0.451
|
0.448
|
2.976E-15
|
822
|
0.129
|
0.128
|
6gy0A.pdb.gz
|
A class of highly selective inhibitors bind to an active state of PI3K gamma.
|
|
|
15
|
PDB:5itdA
|
0.457
|
0.379
|
3.584E-15
|
995
|
0.116
|
0.095
|
5itdA.pdb.gz
|
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors.
|
|
|
16
|
PDB:6pyuA
|
0.442
|
0.391
|
4.317E-15
|
930
|
0.136
|
0.119
|
6pyuA.pdb.gz
|
Design of selective PI3K delta inhibitors using an iterative scaffold-hopping workflow.
|
|
|
17
|
PDB:7lq1A
|
0.445
|
0.387
|
4.738E-15
|
950
|
0.125
|
0.107
|
7lq1A.pdb.gz
|
Discovery of a new series of PI3K-delta inhibitors from Virtual Screening.
|
|
|
18
|
PDB:5dxtA
|
0.457
|
0.426
|
5.978E-15
|
879
|
0.113
|
0.105
|
5dxtA.pdb.gz
|
The Rational Design of Selective Benzoxazepin Inhibitors of the alpha-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326).
|
|
|
19
|
PDB:5swpA
|
0.462
|
0.361
|
7.542E-15
|
1060
|
0.129
|
0.099
|
5swpA.pdb.gz
|
Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.
|
|
|
20
|
PDB:2y3aA
|
0.478
|
0.404
|
1.201E-14
|
976
|
0.135
|
0.113
|
2y3aA.pdb.gz
|
Structure of Lipid Kinase P110Beta-P85Beta Elucidates an Unusual Sh2-Domain-Mediated Inhibitory Mechanism.
|